DevilDog132 on Paul Mampilly’s 100x deal / Mar 2, 12:08pm

SLGG up over 20% today. Yesterday this was out, so maybe this explains why, as I am not seeing other news.Super Leag...

gkissi on $2 covid pharma stock / Jun 4, 11:40am

I believe he's talking about OPK (OPKO HEALTH INC). Here's a headline I found on briefing.com: Opko Health: FDA has auth...

Setting aside how most Gumshoers regard Altucher, SSTI had a wonderful price run up in Jan 2019 and then based/traded si...

Travis, Here is a summary of IIPR's recent activity (2/13/19) from Briefing.com which (as it seems to me) is causing the...

I don't like Yahoo Finance much anymore, they no longer collect much useful information outside of the basic fundamental...

My favorite summary sources for that kind of basic info are YCharts and Briefing.com, though neither is free....

FYI, I saw a news brief dated 1/9/2018 stating "BIVV ...will acquire all shares in FIVE Inc, making it a subsidiary of t...

Another note about the focus on this sector, from briefing.com this morning:Qualcomm Incorporated (QCOM...

$SNNA No PositionFrom Briefing.comSTORY STOCKS® | Updated: 21-Aug-17 | Archive | Add to Column Alerts Brief...

$ AFMD longFrom Briefing.comExelixis (EXEL) initiated with Buy and $33 tgt, Affimed Therapeutics (AFMD) with Buy...

$SCYXBriefing.com in-play article:--The first oral presentation (#OS0846) described new data from a multicenter ...

$AKAO: -How much weight should one place on financial analyst opinions on stock recommendations? IMO, this provides th...

Here's the first really optimistic growth forecast I've seen for STM lately, based largely on the fact that they've appa...

Update today from Briefing.com:Himax Tech target raised to $14 at Craig Hallum -- It’s looking more an...

Actinum Pharma to provide clinical update on Actimab-A at upcoming 2015 ASCO annual meeting on Sunday, May 31 Briefing....

Also Robert Re; $NBY Briefing.com is reporting that shares were halted at 3:43PM because of good news. http://finance.y...

hedy1234 on Payola from Portola? / Nov 13, 12:13pm

Akebia Therapeutics misses by $0.02Briefing.com - 7:05 AM ET, 11/10/2014Reports Q3 (Sep) loss of $0.47 per share...

lskulow on Tetchy on Tekmira: Time to Short this RNAi Play? / Oct 6, 8:40am

YES!!!! Durata Therapeutics to be acquired by Actavis (ACT) for $23.00/share in cash, or ~$675 million in the aggregate...